Abstract
The availability of a panel of protein or genetic biomarkers that can differentiate sepsis from Systemic Inflammatory Response Syndrome (SIRS) earlier and also identify different response patterns caused by different etiological agents, may cause significant impact on morbidity and mortality of neonatal sepsis, contributing to the reduction of hospital costs and also differentiate a good …